Natshield isn't the only product HCT is involved in. With respect to CV see 20 Feb Announcement.
Good Partnerships are one of the hardest things to establish when you enter a new market/country.
The fact that you have a starting base in Korea, Malaysia is a huge start even if it is noodles, which by the way are countries who are massive noodle eaters. This brings opportunity for sanitiser products to be introduced into these countries, assuming that you can supply.
We all know that in this climate health products are sold well above premium due to demand.
20 Feb Announcement:
HOLISTA PARTNERS GLOBAL INFECTIOUS CONTROL CONSULTANTS LLC, THE U.S. DEVELOPER
OF PATH-AWAY®, TO CO-DEVELOP NASAL SANITISING BALM FOR GLOBAL MARKETS.
HOLISTA EXTENDS DISTRIBUTION OF PATH-AWAY® BASED NATSHIELD™ SANITISER TO
INCLUDE ASEAN, UK AND EUROPE.
Natshield isn't the only product HCT is involved in. With...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.673M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.591K | 265.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1084379 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 115724 | 1 |
View Market Depth
| Last trade - 11.57am 21/06/2024 (20 minute delay) ? |
| HCT (ASX) Chart |